Drug intelligence / Profile preview

miR-10b precursor hairpin inhibitor

Development stage
Preclinical
Lead developer
University of Texas MD Anderson Cancer Center
Modality
RNA Therapeutics → Nucleic Acid Therapeutics, Small Molecules
Administration
Intratumoral, Intravenous, Intrathecal
01

Overview

miR-10b precursor hairpin inhibitor is an experimental therapeutic agent designed to selectively target the structured precursor hairpin of microRNA-10b (miR-10b). By binding to the RNA architecture of the precursor, the inhibitor disrupts the Dicer-mediated processing required for the maturation of miR-10b. miR-10b is a well-characterized oncomiR that is significantly upregulated in glioblastoma (GBM), where it drives tumor progression and invasion by silencing tumor suppressors such as PTEN and HOXD10. The inhibition of miR-10b maturation leads to the reactivation of these suppressor pathways, effectively suppressing GBM cell proliferation and invasive behavior in patient-derived models and human cerebral organoids. This approach represents a precision medicine strategy that targets noncanonical oncogenic mechanisms while minimizing effects on normal neural tissue.

Other names
RNA structure-targeted miR-10b inhibitorpre-miR-10b inhibitorpre-miR10b inhibitorpre-miR 10b inhibitor
02

Targets

miR-10b (microRNA 10b)pre-miR-10b (MicroRNA 10b precursor)

Beyond the preview

Go deeper on miR-10b precursor hairpin inhibitor.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on miR-10b precursor hairpin inhibitor.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call